Symptom and Viral RNA Rebound Common After Mild, Moderate COVID-19

TUESDAY, Feb. 21, 2023 (HealthDay News) -- For outpatients with mild-to-moderate COVID-19, symptom rebound and viral RNA rebound are relatively common, but the combination of symptom and viral rebound is rare, according to a study published online Feb. 21 in the Annals of Internal Medicine.
Rinki Deo, Ph.D., from Harvard Medical School in Boston, and colleagues conducted a multicenter trial to characterize symptom and viral rebound in 563 untreated outpatients with mild-to-moderate COVID-19 in a retrospective analysis of a randomized trial. The severity of 13 symptoms was recorded daily between days 0 and 28 for participants receiving placebo in a placebo-controlled trial. On days 0 to 14, 21, and 28, nasal swabs were collected for severe acute respiratory syndrome coronavirus 2 RNA testing.
The researchers found that 26 percent of patients had symptom rebound at a median of 11 days after initial symptom onset. In 31 and 13 percent of participants, respectively, viral rebound and high-level viral rebound were detected. Symptom and viral rebound events were mainly transient; 89 and 95 percent of symptom and viral rebound events, respectively, occurred at a single time point before improving. Only 3 percent of participants had a combination of symptom and high-level viral rebound.
"These results provide insight into the natural trajectory of viral rebound and symptom relapses during COVID-19, which is critical in the interpretation of studies reporting biphasic disease courses after nirmatrelvir-ritonavir or other antiviral treatment," the authors write.
Related Posts
La pandemia trajo un aumento en las sobredosis de drogas letales entre los adolescentes de EE. UU.
MARTES, 12 de abril de 2022 (HealthDay News) -- Las muertes por sobredosis de...
Genes ‘Switched On’ Much Earlier in Human Embryos Than Thought
MONDAY, Dec. 27, 2021 (HealthDay News) -- Genes in human embryos become active...
Medication for Opioid Use Disorder Dispensed More After Medicare Policy Change
THURSDAY, May 25, 2023 (HealthDay News) -- Medicare payment and COVID-19 policy...